Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.68M Sell
18,272
-5,109
-22% -$756K 0.31% 90
2022
Q3
$3.47M Sell
23,381
-720
-3% -$120K 0.45% 61
2022
Q2
$4.14M Sell
24,101
-3,336
-12% -$577K 0.53% 52
2022
Q1
$5.17M Buy
27,437
+259
+1% +$51.2K 0.53% 52
2021
Q4
$6.63M Buy
27,178
+670
+3% +$147K 0.63% 44
2021
Q3
$5.15M Buy
26,508
+1,332
+5% +$269K 0.54% 54
2021
Q2
$4.69M Buy
25,176
+1,831
+8% +$318K 0.48% 60
2021
Q1
$3.68M Buy
+23,345
New +$3.7M 0.41% 65

Other funds holding ZTS

Bank of the West's ZTS Position: Q4 2022 in Review

Bank of the West reduced its Zoetis (ZTS) stake by 22% in Q4 2022, selling an estimated $756K and leaving 18,272 shares worth $2.68M. The position accounts for 0.31% of the portfolio, ranked #90.

Bank of the West first reported a position in ZTS in Q1 2021 and has held it in 8 quarters since. The position peaked at $6.63M in Q4 2021. 1,521 funds tracked by Wall St. Rank hold ZTS as of Q4 2022.

  • Bank of the West held 18,272 shares of Zoetis worth $2.68M as of Q4 2022.
  • Bank of the West sold 5,109 Zoetis shares in Q4 2022, an estimated $756K.
  • Zoetis made up 0.31% of Bank of the West's portfolio in Q4 2022, its #90 holding.
  • Bank of the West first reported a position in Zoetis in Q1 2021 and has held it in 8 quarters since.
  • Bank of the West's Zoetis position peaked at $6.63M in Q4 2021.
  • 1,521 funds tracked by Wall St. Rank held Zoetis as of Q4 2022.

Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.